Maybe I've been reading The Onion too long, but I'
Post# of 144910
![Avatar](/images/ProfileImages/638208941_60089_bobloblaw2.jpg)
"CytoDyn Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab, IS STILL BROKE"
Don't get me wrong, I am very pleased with today's news. It's unequivocally positive that leronlimab has another potential indication.
However, none of the more-recent developments (colon cancer IND, NASH IND, PREP, etc.) will matter until financing is settled.
Would love to be wrong and watch us be up 25% today, but we all know that isn't in the cards.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)